KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Shares Issued (2016 - 2025)

Boston Scientific's Shares Issued history spans 17 years, with the latest figure at $20.0 million for Q4 2025.

  • For Q4 2025, Shares Issued fell 28.57% year-over-year to $20.0 million; the TTM value through Dec 2025 reached $282.0 million, up 22.61%, while the annual FY2025 figure was $282.0 million, 22.61% up from the prior year.
  • Shares Issued for Q4 2025 was $20.0 million at Boston Scientific, down from $115.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $115.0 million in Q1 2025 and bottomed at $6.0 million in Q2 2022.
  • The 5-year median for Shares Issued is $30.0 million (2024), against an average of $47.0 million.
  • The largest annual shift saw Shares Issued plummeted 97.86% in 2021 before it soared 350.0% in 2023.
  • A 5-year view of Shares Issued shows it stood at $8.0 million in 2021, then soared by 137.5% to $19.0 million in 2022, then decreased by 10.53% to $17.0 million in 2023, then skyrocketed by 64.71% to $28.0 million in 2024, then fell by 28.57% to $20.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Shares Issued are $20.0 million (Q4 2025), $115.0 million (Q3 2025), and $32.0 million (Q2 2025).